21 Medicare Health Plans Warned To Fix Provider Directory Errors
Federal officials release names of insurers who ranked poorly in a recent review of their online directories’ accuracy.
The independent source for health policy research, polling, and news.
2,641 - 2,660 of 3,967 Results
Federal officials release names of insurers who ranked poorly in a recent review of their online directories’ accuracy.
Orphan drugs for rare diseases have helped or saved hundreds of thousands of patients like 2-year-old Luke Whitbeck, but families and insurers are picking up the astronomical cost.
Drugmakers have brought almost 450 orphan drugs to market and collected rich incentives but nearly a third of those products aren’t new or were repurposed multiple times, an investigation shows.
Follow the twists and turns of the orphan drug industry over the past three decades.
Check out all the drugs the FDA has approved to treat rare diseases. You can search by brand name, or by disease, and see familiar names that were first sold on the mass market or all the drugs that won FDA approval to treat more than one rare disease.
The former Congressman championed the Orphan Drug Act decades ago but now he fears it’s being manipulated to make money.
President-elect Donald Trump’s Cabinet pick Tom Price "assisted" a company and campaign donor who tapped executives with an urgent request to donate.
A high-profile whistleblower attorney representing the physician is seeking class action status.
The FDA and other agencies are loosening restrictions on hearing aid sales and opening the door to less expensive, over-the-counter products.
An Obama administration veteran will take the helm of Cal INDEX as it combines with the Inland Empire Health Information Exchange, creating a database covering nearly 17 million patients.
President Barack Obama succeeded where many other presidents failed, but now the fate of the Affordable Care Act rests with President-elect Donald Trump.
Rep. Tom Price advocated on everything from a sperm test to a hot pepper ingredient on behalf of medical interests that included campaign donors.
AARP had sought a preliminary injunction because it argued the new regulations – which allow employers to tie participation to 30 percent of the cost of individual health coverage – could be coercive.
People in these facilities are now guaranteed more flexibility on food and roommate choices, as well as improved procedures for grievances and discharges.
In a number of states, including big ones such as New York and Texas, leading cancer centers aren’t included in insurers’ provider networks.
Investigators claim drugmaker employees met in secret at restaurants, golf outings and at “Girls Night Out” to raise generic drug prices.
Medicare reduced payments to 769 hospitals in the program, punishing facilities that have high rates of patient injuries, including infections, blood clots, falls and bed sores. This year, federal officials also added the prevalence of two dangerous bacteria.
As Medicare considers paying for knee replacement procedures outside the hospital, doctors debate patient choice and the potential for post-operation complications.
Hospitals rarely help patients find the best nursing home. When they do advise, hospitals sometimes push their own facilities.
Lawyers who deposed top company officials in a civil case say they declined to answer questions about their failure to warn American hospitals of infection risks. Industry giant Olympus also is the subject of a criminal probe.
© 2026 KFF